Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia
Status:
Completed
Trial end date:
2009-08-31
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the safety, efficacy, and tolerability of cariprazine (RGH-188)
relative to placebo in adult patients (18-60 years of age) with acute exacerbation of
schizophrenia.